Clinical study shows Immun'Âge helps improve symptoms for Electrohypersensitive patients

Overall, clinical improvements were obtained in 50-60% of cases, showing a diminution of oxidative stress and inflammatory phenomena, as well as a normalization of brain oxygenation.

For these patients, this resulted in fewer and milder clinical symptoms such as headaches, fatigue, tachycardia episodes, insomnia, and attention deficit to name a few.

Clinical study shows

  • Brain oxygenation

    After 6 months of supplementation with Immun'Âge, the vascular flow returned to normal values with normalization of brain oxygenation.

  • Fatigue symptoms

    82 % patients reported improvement or major improvement after 6 months.

  • Tachycardia episodes

    The number of patients experimenting tachycardia decreased by 63 %

    The average number of tachycardia episodes were reduced by 72%

US Patent for EHS Treatment

Based on this study, Osato International was granted the US patent

N°US10.993.980B2 for "METHOD OF TREATING ELECTROHYPERSENSITIVITY WTH A FERMENTED PAPAYA PREPARATION"

interview

Pr. Dominique Belpomme

Oncologist, Specialist in Environmental Diseases

President of ARTAC, Therapeutic Cancer Research Association
President of ECERI, European Institute for Research on Environment and Cancer

How to use Immun'Âge?

The study shows that best results are obtained after 6 months of supplementation.

Month 1 to 3: 1-2 packets/day for 2-3 months, 3-4 times a week

Action: Helps body to improve its antioxidative mechanism and the flow mediated dilation.

Result: Helps protect body against endothelial dysfunction, ensuring cardiovascular health.